Recent Company News

• 11:55 AM ET May 07, 2025
  

  Valneva issues update following European Medicines Agency suspension announcement on use of IXCHIQ for individuals over 65 years old (€2.93, 0.00)

• 04:22 AM ET Apr 28, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:06 AM ET May 07, 2025
  

  Valneva reports Q1 net income (€9.2M) vs FactSet (€24.9M) [3 est, (€31.4)-(16.3M)] (€2.89, 0.00)

• 01:03 PM ET May 02, 2025
  

  EMA's PRAC and ETF comment on the safety of Ixchiq (€2.91, 0.00)

• 02:56 AM ET Apr 28, 2025
  

  StreetAccount Summary - European pre-market trading update

• 08:22 PM ET Apr 26, 2025
  

  France suspends use of Valneva's IXCHIQ in people 65 and older following reports of SAEs (€3.15, 0.00)

• 04:32 PM ET Apr 22, 2025
  

  INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

• 08:29 AM ET Apr 17, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:56 PM ET Apr 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market